Gentium Announces Final Clinical Trial Results for Defibrotide Presented at the American Society of Hematology Conference
Posted by: DrugsNews on: 08 Dec, 2009
- In: Drugs News| News
- Comment!
Gentium Announces Final Clinical Trial Results for Defibrotide Presented at the American Society of Hematology Conference
Defibrotide Therapy Demonstrates a Strong Trend Toward
Statistical Significance in the Prevention and Treatment of
VOD
VILLA GUARDIA (COMO), Italy–(BUSINESS WIRE)–Dec 8, 2009 -
Gentium S.p.A. (NASDAQ: GENT) today announced final clinical…
Read more about Gentium Announces Final Clinical Trial Results for Defibrotide Presented at the American Society of Hematology Conference
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- Gentium Announces Presentation of Defibrotide Clinical Data at the American Society of Hematology Annual Meeting
- Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
- Data from Three Phase II Trials to be Presented at the 51st American Society of Hematology Annual Meeting Demonstrate that INCB18424, a Selective JAK1/JAK2 Inhibitor, Has Potential in Multiple Hematology Conditions
